Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

US CDC to lift COVID testing requirements for travelers from China

Published 03/08/2023, 02:04 PM
Updated 03/08/2023, 07:25 PM
© Reuters. FILE PHOTO: Passengers walk in the terminal at Ronald Reagan Washington National Airport as a budding winter storm across the much of the country is likely to cause travel delays ahead of the Christmas holiday, in Arlington, Virginia, U.S., December 20, 2

By David Shepardson

WASHINGTON (Reuters) -The U.S. Centers for Disease Control and Prevention (CDC) confirmed on Wednesday it plans to end mandatory COVID-19 tests for travelers from China, joining other countries in eliminating the requirements.

Reuters and other outlets on Tuesday reported that the CDC plans to drop the testing requirements imposed in early January on Friday.

The CDC said on Wednesday that the "public health measure was put in place to protect U.S. citizens and communities as we worked to both identify the size of the (China COVID) surge and gain better insights into the variants that were circulating."

The CDC said it will continue to monitor cases in China and around the world.

Last week, Japan dropped a requirement that everyone take a test for the virus upon arrival from China.

The United States in early January joined other countries in taking new measures after Beijing's decision to lift its stringent zero-COVID policies. It required air passengers ages 2 years and older to get a negative COVID test result no more than two days before departure from China, Hong Kong or Macao.

"We were aware that there was a large wave of infections in (China) and there was a lack of transparency by the PRC, meaning we had little information about the size of the surge or the variants that were circulating within," the CDC said.

The agency said it will continue the genomic sequencing program at select airports that asks travelers to volunteer to help with early detection of new COVID variants.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The Traveler-based Genomic Surveillance Program will monitor flights from China and regional transportation hubs, as well as flights from more than 30 other countries, the CDC said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.